SCHEMBL9684229

SCHEMBL9684229

C/C(=C\C(=O)O)c1ccc(CCC(C)N(CCc2ccccc2O)CC(O)COc2ccccc2)s1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.34
ABCB1 P08183 5/20 0.34
ALDH1A1 P00352 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ADRB2 P07550 2/20 0.32
ADRB1 P08588 2/20 0.32
ADRB3 P13945 2/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
POLB P06746 1/20 0.31
LMNA P02545 1/20 0.31
BCHE P06276 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9684235 1.00 KCNH2 (0.34) KCNH2ABCB1ALDH1A1MEN1KMT2A
SCHEMBL9683733 0.88 ABCB1 (0.36) KCNH2ABCB1ALDH1A1MEN1KMT2A
SCHEMBL9683741 0.88 ABCB1 (0.36) KCNH2ABCB1ALDH1A1MEN1KMT2A
SCHEMBL9684909 0.83 ABCB1 (0.43) ABCB1ALDH1A1ADRB2ADRB1ADRB3
SCHEMBL9684987 0.80 ABCB1 (0.42) ABCB1ALDH1A1MEN1KMT2AADRB2
SCHEMBL9684985 0.80 ABCB1 (0.42) ABCB1ALDH1A1MEN1KMT2AADRB2
SCHEMBL9683706 0.77 NR1H3 (0.35) ABCB1ADRB2ADRB1ADRB3
SCHEMBL9684099 0.77 ABCB1 (0.42) ABCB1ALDH1A1MEN1KMT2AADRB2
SCHEMBL9684091 0.77 ABCB1 (0.42) ABCB1ALDH1A1MEN1KMT2AADRB2
SCHEMBL9812018 0.77 ABCB1 (0.43) KCNH2ABCB1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed